Prediction of survival in patients with thin melanoma: results from a multi-institution study.

导出 LinkOut

翻译打印收藏纠错

作者： Andrea,Maurichi ^[1] ; Rosalba,Miceli ^[2] ; Tiziana,Camerini ^[2] ; Luigi,Mariani ^[2] ; Roberto,Patuzzo ^[2] ; Roberta,Ruggeri ^[2] ; Gianfranco,Gallino ^[2] ; Elena,Tolomio ^[2] ; Gabrina,Tragni ^[2] ; Barbara,Valeri ^[2] ; Andrea,Anichini ^[2] ; Roberta,Mortarini ^[2] ; Daniele,Moglia ^[2] ; Giovanni,Pellacani ^[2] ; Sara,Bassoli ^[2] ; Caterina,Longo ^[2] ; Pietro,Quaglino ^[2] ; Nicola,Pimpinelli ^[2] ; Lorenzo,Borgognoni ^[2] ; Daniele,Bergamaschi ^[2] ; Catherine,Harwood ^[2] ; Odysseas,Zoras ^[2] ; Mario,Santinami ^[2]

作者单位： Andrea Maurichi, Rosalba Miceli, Tiziana Camerini, Luigi Mariani, Roberto Patuzzo, Roberta Ruggeri, Gianfranco Gallino, Elena Tolomio, Gabrina Tragni, Barbara Valeri, Andrea Anichini, Roberta Mortarini, Daniele Moglia, Mario Santinami, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori, Milan; Giovanni Pellacani, Sara Bassoli, Caterina Longo, University Hospital of Modena and Skin Cancer Unit IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia; Pietro Quaglino, University Hospital of Turin, Turin; Nicola Pimpinelli, Lorenzo Borgognoni, University Hospital of Florence and Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence, Italy; Daniele Bergamaschi, Catherine Harwood, Queen Mary University of London, London, United Kingdom; and Odysseas Zoras, University Hospital of Heraklion, Crete, Greece. andrea.maurichi@istitutotumori.mi.it. ^[1] Andrea Maurichi, Rosalba Miceli, Tiziana Camerini, Luigi Mariani, Roberto Patuzzo, Roberta Ruggeri, Gianfranco Gallino, Elena Tolomio, Gabrina Tragni, Barbara Valeri, Andrea Anichini, Roberta Mortarini, Daniele Moglia, Mario Santinami, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori, Milan; Giovanni Pellacani, Sara Bassoli, Caterina Longo, University Hospital of Modena and Skin Cancer Unit IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia; Pietro Quaglino, University Hospital of Turin, Turin; Nicola Pimpinelli, Lorenzo Borgognoni, University Hospital of Florence and Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence, Italy; Daniele Bergamaschi, Catherine Harwood, Queen Mary University of London, London, United Kingdom; and Odysseas Zoras, University Hospital of Heraklion, Crete, Greece. ^[2]